EP1001777A4 - Antagonistes du recepteur de fibrinogene - Google Patents

Antagonistes du recepteur de fibrinogene

Info

Publication number: EP1001777A4
Authority: EP; European Patent Office
Prior art keywords: receptor antagonists; fibrinogen receptor; fibrinogen; antagonists; receptor
Prior art date: 1997-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98935967A

Other languages

German (de)

English (en)

Other versions

EP1001777A1 (fr

Inventor

Dirk Heerding

James M Samanen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-25

Filing date

1998-07-23

Publication date

2002-10-09

1998-07-23 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2000-05-24 Publication of EP1001777A1 publication Critical patent/EP1001777A1/fr

2002-10-09 Publication of EP1001777A4 publication Critical patent/EP1001777A4/fr

Status Withdrawn legal-status Critical Current

Links

239000002319 fibrinogen receptor antagonist Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP98935967A 1997-07-25 1998-07-23 Antagonistes du recepteur de fibrinogene Withdrawn EP1001777A4 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US5378897P	1997-07-25	1997-07-25
US53788P		1997-07-25
US6354597P	1997-10-28	1997-10-28
US63545P		1997-10-28
PCT/US1998/015288 WO1999004796A1 (fr)	1997-07-25	1998-07-23	Antagonistes du recepteur de fibrinogene

Publications (2)

Publication Number	Publication Date
EP1001777A1 EP1001777A1 (fr)	2000-05-24
EP1001777A4 true EP1001777A4 (fr)	2002-10-09

Family

ID=26732245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98935967A Withdrawn EP1001777A4 (fr)	1997-07-25	1998-07-23	Antagonistes du recepteur de fibrinogene

Country Status (6)

Country	Link
EP (1)	EP1001777A4 (fr)
JP (1)	JP2002509547A (fr)
AU (1)	AU8510398A (fr)
CA (1)	CA2297909A1 (fr)
CO (1)	CO4970784A1 (fr)
WO (1)	WO1999004796A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997025323A1 (fr) *	1996-01-11	1997-07-17	Smithkline Beecham Corporation	Antagonistes du recepteur du fibrinogene

1998
- 1998-07-23 WO PCT/US1998/015288 patent/WO1999004796A1/fr not_active Ceased
- 1998-07-23 CA CA002297909A patent/CA2297909A1/fr not_active Abandoned
- 1998-07-23 JP JP51008299A patent/JP2002509547A/ja active Pending
- 1998-07-23 EP EP98935967A patent/EP1001777A4/fr not_active Withdrawn
- 1998-07-23 AU AU85103/98A patent/AU8510398A/en not_active Abandoned
- 1998-07-24 CO CO98042201A patent/CO4970784A1/es unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997025323A1 (fr) *	1996-01-11	1997-07-17	Smithkline Beecham Corporation	Antagonistes du recepteur du fibrinogene

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9904796A1 *

Also Published As

Publication number	Publication date
AU8510398A (en)	1999-02-16
EP1001777A1 (fr)	2000-05-24
CO4970784A1 (es)	2000-11-07
JP2002509547A (ja)	2002-03-26
WO1999004796A1 (fr)	1999-02-04
CA2297909A1 (fr)	1999-02-04

Legal Events

Date	Code	Title	Description
2000-04-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-05-24	17P	Request for examination filed	Effective date: 20000117
2000-05-24	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): BE CH DE ES FR GB IT LI NL
2002-10-09	A4	Supplementary search report drawn up and despatched	Effective date: 20020826
2002-10-09	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): BE CH DE ES FR GB IT LI NL
2002-10-09	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 31/495 A, 7C 07D 237/00 B, 7C 07D 211/62 B
2004-03-17	17Q	First examination report despatched	Effective date: 20040128
2004-10-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-12-08	18D	Application deemed to be withdrawn	Effective date: 20040508
2007-03-02	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1028552 Country of ref document: HK

Publication	Publication Date	Title
EP0912175A4 (fr)	1999-09-08	Antagonistes du recepteur de fibrinogene
HU9603525D0 (en)	1997-02-28	Vironectin receptor antagonists
EP0885213A4 (fr)	1999-04-28	Antagonistes du recepteur du fibrinogene
HU9801861D0 (en)	1998-10-28	Ccr-3 receptor antagonists
GB9405317D0 (en)	1994-04-27	Fibrinogen receptor antagonists
EP1007051A4 (fr)	2001-08-29	Antagonistes du recepteur de l'integrine
IL135797A0 (en)	2001-05-20	Thrombin receptor antagonists
IL130760A0 (en)	2001-01-28	Vitronectin receptor antagonists
EP0796098A4 (fr)	1998-04-29	Antagonistes des recepteurs du fibrinogene
EP0801650A4 (fr)	1998-05-06	Antagonistes des recepteurs du fibrinogene
HU9502028D0 (en)	1995-09-28	Fibrinogen receptor antagonists
IL135028A0 (en)	2001-05-20	Vitronectin receptor antagonists
EP1027337A4 (fr)	2002-04-03	Antagonistes des recepteurs d'integrines
IL134301A0 (en)	2001-04-30	2-acylaminopropanamines as tachykinin receptor antagonists
EP0794779A4 (fr)	1998-04-29	Antagonistes des recepteurs du fibrinogene
GB9515852D0 (en)	1995-10-04	Fibrinogen receptor antagonists
IL134155A0 (en)	2001-04-30	2-acylaminopropanamines as tachykinin receptor antagonists
EP0800395A4 (fr)	1998-04-29	Antagonistes des recepteurs du fibrinogene
GB9516643D0 (en)	1995-10-18	Fibrinogen receptor antagonists
AU6826498A (en)	1998-10-12	Endotholin receptor antagonists
GB9702834D0 (en)	1997-04-02	Fibrinogen receptor antagonists
EP1001777A4 (fr)	2002-10-09	Antagonistes du recepteur de fibrinogene
GB9708766D0 (en)	1997-06-25	Fibrinogen receptor antagonist
GB9603371D0 (en)	1996-04-17	Fibrinogen receptor antagonists
GB9613688D0 (en)	1996-08-28	Fibrinogen receptor antagonists